Dr. Robert Anthony Delapenha, MD

Dr. Delapenha practices at Heart To Hand, Inc in Upper Marlboro, Maryland.

Dr. Delapenha's NPI, 1942351291, was assigned on January 15, 2007. Dr. Delapenha graduated from University of the West Indies Faculty of Medical Sciences in 1980. Dr. Delapenha holds District of Columbia license MD14569.

Dr. Delapenha's primary practice is Heart To Hand, Inc, at 9701 Apollo Dr, Upper Marlboro, MD 20774 in Prince Georges County. The practice phone is (301) 772-0103.

Dr. Delapenha's primary practice is Heart To Hand, Inc in Upper Marlboro, Maryland. Dr. Delapenha is also affiliated with Howard University Hospital. The medical group on file is Heart to Hand. Dmand AI also links Dr. Delapenha to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Delapenha practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Delapenha's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Delapenha is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Delapenha's licenses on file in 2 states: District of Columbia and Maryland.

Dmand AI lists cellulitis, hiv/aids, pneumonia and respiratory infection, sepsis and urinary tract infection among the conditions Dr. Delapenha treats.

CMS data shows 545 Medicare services from Dr. Delapenha across 7 procedure codes in 2024, for 153 Medicare patients. Medicare paid $47,528 for them.

CMS counts 153 Medicare patients who saw Dr. Delapenha in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 54% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Delapenha's median patient age at 61, with 38% women.

In 2024, Dr. Delapenha wrote 1,428 Medicare Part D claims for 107 patients. 55% of them were for generic drugs. CMS names the drug for 1,101 of them, across 34 drugs with 11 or more claims each, at $2,151,954 in total drug cost. In 2023, CMS named 1,034 claims across 35 drugs.

Dr. Delapenha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Delapenha as offering telehealth.

Dmand AI links 16 papers to Dr. Delapenha, published from 2000 to 2021. The most frequent topics are HIV Infections, CD4 Lymphocyte Count and HIV-1. Dr. Delapenha has published most often in J Acquir Immune Defic Syndr. Dr. Delapenha's most frequent co-authors are Alexandra M. Levine, MD, David Michael Burns, MD and Howard Minkoff, MD.

CMS Open Payments shows 246 general payments to Dr. Delapenha from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 43% of the total. Gilead Sciences, Inc. paid the most, $8,150.

Dmand AI lists 1 award for Dr. Delapenha, most recently CMS Stage 1 EHR in 2013.

Dr. Delapenha graduated from University of the West Indies Faculty of Medical Sciences in 1980.

Dr. Delapenha is in network with 17 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.